• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep adhd and anxiety medication medication during pregnancy and breastfeeding is a challenge for women suffering from the condition. Little data exists about how long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must evaluate the benefits of using it against the possible risks for the fetus. Physicians don't have the data to make unambiguous recommendations but they can my general practitioner prescribe adhd medication provide information about risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face an increased risk of fetal heart malformations or major structural birth defects. Researchers used a large population-based case control study to compare the incidence of major structural defects in infants born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

The research conducted by the researchers had some limitations. Most important, they were unable to distinguish the effects of the medication from those of the disorder at hand. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medication or caused by co-morbidities. The researchers also did not look at the long-term effects for the offspring.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean delivery or having a baby born with an low Apgar score (less than 7). These increases did not seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications during early pregnancies could be offset by the greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies for improving their coping skills that may minimize the impact of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether or not to end treatment during pregnancy is one that more and more doctors face. These decisions are usually made without clear and reliable evidence. Instead, doctors must weigh their own knowledge in conjunction with the experiences of other doctors, and the research on the topic.

The issue of possible risks to the infant can be difficult to determine. The research on this issue is based on observation rather than controlled studies and a lot of the results are conflicting. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both the data from deceased and live births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects however, other studies haven't found a correlation. Most studies show that there is a neutral, or somewhat negative, impact. As a result, a careful risk/benefit analysis is required in every situation.

For women suffering from ADHD and ADD, the decision to stop taking medication is difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. In addition, a decrease in medication can affect the ability to perform job-related tasks and drive safely that are crucial aspects of daily life for many people with ADHD.

She suggests women who are uncertain about whether to continue or stop taking medication because of their pregnancy, consider informing family members, friends and colleagues about the condition, its impact on daily functioning, and the benefits of keeping the current treatment regimen. In addition, educating them can make the woman feel more comfortable when she is struggling with her decision. It is important to remember that certain drugs can pass through the placenta, therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the medication could be transferred to the child.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the drugs might have on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two huge data sets to study over 4.3 million pregnancy and determine if stimulant medication use increased birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers behind the study found no connection between early use of medication and congenital abnormalities like facial clefting, or club foot. The findings are in line with previous studies revealing the presence of a small, but significant increase in the risk of heart malformations among women who began taking ADHD medications prior to pregnancy. This risk increased in the latter half of pregnancy, when many women are forced to stop taking their ADHD medication.

Women who used adhd medication for women medications during the first trimester of pregnancy were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance at birth. The authors of the study were not able to eliminate selection bias because they limited their study to women with no other medical conditions that might have contributed to the findings.

The researchers hope their study will help inform the clinical decisions of physicians who treat pregnant women. They advise that while the discussion of the risks and benefits is crucial but the decision to stop or maintain treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, while stopping adhd medication adults the medication is a possibility to look into, it is not recommended due to the high rate depression and mental health issues in women who are expecting or have recently given birth. Additionally, research suggests that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.

Nursing

It can be a challenge to become a mother. Women with ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of their child and adapting to new routines in the home can experience severe challenges. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medications are absorbed by breast milk in very small quantities, so the risk to the infant who is breastfeeding is low. However, the frequency of exposure to medication by the newborn can vary depending on the dosage, frequency it is administered and at what time it is administered. In addition, different medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't completely comprehended.

Because of the lack of research, some physicians may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a difficult decision for the woman, who must weigh the benefits of continuing her medication against the risk to the embryo. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they are taking or planning to take medication during the perinatal period.

A growing number of studies have shown that women can continue to take their ADHD medication during pregnancy and breastfeeding. This has led to many patients choose to do so, and after consulting with their doctor, they have discovered that the benefits of continuing their current medication outweigh any risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and build strategies for coping. This should include an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a treatment plan for both mother and child, as well as monitoring for signs of deterioration, and, if necessary, Can My general practitioner prescribe adhd medication adjustments to the best medication for ocd and adhd regimen.